Federal contract award

75Q80120F32001

TASK ORDER 1 FOR CORE SURVEY WORK (CLIN0001) AND OPTIONAL SURVEY ADD-ONS (CLIN0002)

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeOMAS STRATEGIC BUYING CENTER - HHS MISSION
NAICS518210 — Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
PSCR422 — Market Research and Public Opinion Services (includes telephone and field interviews, focus testing, and surveys)
Parent award / vehicle75Q80120D00024
Set-asideNot reported
Pricing typeCOST PLUS INCENTIVE FEE
Obligations$181.8M
Current contract value$181.8M
Potential contract value / ceiling$264.8M
Start dateJul 13, 2020
Current end dateNov 30, 2026
Potential end dateJan 12, 2027
Latest award activityMay 7, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 24 of 24 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 7, 2026P00023$5.8MMEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1.
Apr 7, 2026P00022$0MEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1.
Dec 1, 2025P00021$5.8MMEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1. THE PURPOSE OF THIS MODIFICATION IS TO: EXERCISE CLIN001G (OP6) IN THE AMOUNT OF $11,678,230.00
Aug 15, 2025P00020$3.3MMEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1. THE PURPOSE OF THE PROPOSED MODIFICATION IS TO ENSURE THE CONTINUATION OF THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS) HOUSEHOLD COMPONENT (HC) AND TO INCREMENTALLY FUND
Jul 10, 2025P00019$5.5MMEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1. THE PURPOSE OF THE PROPOSED MODIFICATION IS TO ENSURE THE CONTINUATION OF THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS) HOUSEHOLD COMPONENT (HC) AND TO INCREMENTALLY FUND
May 15, 2025P00018$5.0MMEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1. THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLIN0001F/OPY5 IN THE AMOUNT OF $5,000,000. INCREMENTAL FUNDING IS EXPECTED TO LAST THROUGH JUNE 18, 2025. TH
Apr 9, 2025P00017$0MEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1. THE PURPOSE OF THIS MODIFICATION IS TO: FINALIZE THE INCENTIVE FEE DETERMINATION FOR OP4 BY CONVERTING THE CLIN TO FFP AND CHANGE THE CONTRACT SPECIALIST FROM TARA BERT
Jan 31, 2025P00016$9.5MMEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1. THE PURPOSE OF THIS MODIFICATION IS TO: INCREMENTALLY FUND CLIN0001F (OP5) IN THE AMOUNT OF $9,500,000. FUNDING IS EXPECTED TO LAST THROUGH 4/18/25.
Nov 26, 2024P00015$2.0MMEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1. THE PURPOSE OF THIS MODIFICATION IS TO: EXERCISE OP5 IN THE AMOUNT OF $25,330,609 AND INCREMENTALLY FUND BY $2,035,686.
May 15, 2024P00014$20.9MMEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1. THE PURPOSE OF THIS MODIFICATION IS TO: FULLY FUND CLIN0001E (OP4) BY $20,866,667.
Feb 22, 2024P00013$12.9MMEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1. THE PURPOSE OF THIS MODIFICATION IS TO: INCREMENTALLY FUND CLIN0001E (OP4) BY $12,900,000; CONVERT CLIN0001D (OY3) AND CLIN0002B3A TO FFP AS A RESULT OF THE INCENTIVE F
Nov 27, 2023P00012$11.4MMEDICAL EXPENDITURE PANEL SURVEY - HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1. THE PURPOSE OF THIS MODIFICATION IS TO: EXERCISE OPTION PERIOD 4 AND INCREMENTALLY FUND BY $11,400,000.
Feb 1, 2023P00011$37.3MTHE PURPOSE OF THIS MODIFICATION IS TO: 1) FULLY FUND CLIN0001D (OY3) AND CLIN0002B3A; 2) CONVERT CLIN0001C (OY2) TO FFP AS A RESULT OF INCENTIVE FEE RECONCILIATION.
Nov 21, 2022P00010$8.9MMEDICAL EXPENDITURE PANEL SURVEY- HOUSEHOLD COMPONENT (MEPS-HC) TASK ORDER 1 EXERCISE CLIN0001D (OY3) AND MODIFY/EXERCISED CLIN0002B3A
Jul 11, 2022P00009$0UPDATE INVOICE CLAUSES FOR CONVERSION TO IPP SYSTEM
May 3, 2022P00008$15.1MFULLY FUND OY2
Mar 2, 2022P00007$6.5MINCREMENTAL FUNDING FOR OY2 AND CONVERT (CLIN0001B) OY1 TO FFP AS A RESULT OF INCENTIVE FEE DETERMINATION
Jan 12, 2022P00006$5.6MINCREMENTAL FUNDING FOR OY2
Nov 16, 2021P00005$5.5MEXERCISE OPTION YEAR 2
Aug 3, 2021P00004$0INCREASE THE COA ON OPTION 1 AND 2 FOR SOFTDEV SUBCONTRACTOR. NO CHANGE TO CONTRACT VALUE OR FUNDING
Mar 19, 2021P00003$10.3MINCREASE VALUE ON OPTION YEARS 1, 2 AND 3. FULLY FUND OPTION YEAR 1
Feb 2, 2021P00002$6.6MINCREMENTALLY FUND OY1
Nov 19, 2020P00001$2.1MDESCOPE OPTION YEARS 1, 2 AND 3. EXERCISE AND INCREMENTALLY FUND OP1
Jul 8, 20200$1.7MTASK ORDER 1 FOR CORE SURVEY WORK (CLIN0001) AND OPTIONAL SURVEY ADD-ONS (CLIN0002)

Estimated positioning window

Nov 1, 2026 – Jan 30, 2027

Recompete signal:
70/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 70/100. Available recorded signals: 65 points.

Contract end 2027-01-12 (72 days from calculation)
+35 points
3 historical awards in this buyer and category group
+10 points
24 recorded award transactions
+10 points
Latest award action: 2026-05-07
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+0 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Verify whether remaining options may extend performance beyond the current end date.
  3. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  4. Review the award scope and buyer evidence before making a bid/no-bid decision.